HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
Nitrendipin
Nitrendipin · 3-ethyl 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate · Deiten · nidrel · Nitrepin · baye5009 · baypress · bayotensin

Identifikatoren & physikalische Daten
| CAS No. | 39562-70-4 |
|---|---|
| Summenformel | C18H20N2O6 |
| Durchschnittliche Molmasse | 360,4 g/mol |
| Monoisotopische Masse | 360,13213636 g/mol |
| SMILES | CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1 |
| InChIKey | PVHUJELLJLJGLN-UHFFFAOYSA-N |
| PubChem CID | 4507 |
| ChEMBL | CHEMBL3195219 |
| ChEBI | CHEBI:7582 |
| EC No. | 254-513-1 |
| DTXSID | DTXSID0023373 |
| Lokaler Name | Nitrendipin |
Chemische & physikalische Eigenschaften
| XLogP | 2,9 |
|---|---|
| Polarare Oberfläche (TPSA) | 110 |
| H-Brücken-Donoren | 1 |
| H-Brücken-Akzeptoren | 7 |
| Frei drehbare Bindungen | 6 |
| Schwere Atome | 26 |
| Formalladung | 0 |
| Komplexität | 661 |
| LogP (Verteilungskoeffizient) | 2.882.4 |
| Löslichkeit | Insoluble1.42e-02 g/Lmethanol: 15 mg/mLSoluble in DMSO (17.5 mg/ml), methanol (15 mg/ml), ethyl acetate, and ethanol (25 mM). Insoluble in water. |
| Schmelzpunkt | 156-160 °C156 - 160 °C1580C |
| Caco2 Permeability | -4.77 |
| Physical Description | Solid |
| Kovats Retention Index | 2659.11 |
| Collision Cross Section | 181.9 Ų [M+H]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards]182.2 Ų [M+H]+ [CCS Type: TWMethod: Major Mix IMS/Tof Calibration Kit (Waters)]191.32 Ų [M+K]+ [CCS Type: TW180.38 Ų [M+H]+ [CCS Type: TW189.51 Ų [M+Na]+ [CCS Type: TW |
| Siedepunkt | 492.4°C (rough estimate) |
| Dichte | 1.3595 (rough estimate) |
| Brechungsindex | 1.5700 (estimate) |
| Lagerbedingungen | 2-8°C |
| Aggregatzustand | powder |
| pKa (Säurekonstante) | 2.79±0.70(Predicted) |
| Farbe | yellow to green |
| Stabilität | Stable for 1 year from date of purchase as supplied. Protect from light. Solutions in DMSO or ethanol may be stored at -20°C for up to 1 week. |
| InChI | InChI=1S/C18H20N2O6/c1-5-26-18(22)15-11(3)19-10(2)14(17(21)25-4)16(15)12-7-6-8-13(9-12)20(23)24/h6-9,16,19H,5H2,1-4H3 |
| InChIKey | PVHUJELLJLJGLN-UHFFFAOYSA-N |
| SMILES | C1(C)NC(C)=C(C(OC)=O)C(C2=CC=CC([N+]([O-])=O)=C2)C=1C(OCC)=O |
| CAS Datenbank | 39562-70-4(CAS DataBase Reference) |
| NIST chemische Informationen | Nitrendipine(39562-70-4) |
Sicherheit & Vorschriften
| GHS-Einstufung | This chemical does not meet GHS hazard criteria for 1.1% (1 of 95) of reports.WarningH302+H312 (29.5%): Harmful if swallowed or in contact with skin [Warning Acute toxicity, oralacute toxicity, dermal]H302 (29.5%): Harmful if swallowed [Warning Acute toxicity, oral]H312 (73.7%): Harmful in contact with skin [Warning Acute toxicity, dermal]H332 (44.2%): Harmful if inhaled [Warning Acute toxicity, inhalation]H361 (25.3%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]P203, P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P318, P321, P330, P362+P364, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 95 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.Reported as not meeting GHS hazard criteria per 1 of 95 reports by companies.There are 4 notifications provided by 94 of 95 reports by companies with hazard statement code(s).Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. |
|---|---|
| Hazard Classes and Categories | Acute Tox. 4 (29.5%)Acute Tox. 4 (73.7%)Acute Tox. 4 (44.2%)Repr. 2 (25.3%) |
| Drug Induced Liver Injury | Drug-Induced Liver Injury Severity and Toxicity (DILIst)NitrendipineDILI PositiveDOI:10.1016/j.drudis.2019.09.022 |
| Effects During Pregnancy and Lactation | ◉ Summary of Use during LactationBased on limited data, it is unlikely that nitrendipine will reach the infant in clinically important amounts. However, it may be preferable to use another agent drug for which more safety information is available.◉ Effects in Breastfed InfantsRelevant published information was not found as of the revision date. |
Anwendungen & Verwendung
Beschreibung
Nitrendipine is a vasodilating, dihydropyridine calcium antagonist. Its prolonged therapeutic effect in comparison to nifedipine makes it useful in the once to twice daily treatment of hypertension.
Verwenden
Nitrendipine is a dihydropyridine calcium channel blocker. Nitrendipine is used in the treatment of primary (essential) hypertension to decrease blood pressure. Antihypertensive.